Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation

Regulatory Toxicology and Pharmacology

Volumn 38, Issue 1, 2003, Pages 1-16

  Gentry, P Robinan ^a   Covington, Tammie R ^a   Clewell III, Harvey J ^a  

^a ENVIRON INTERNATIONAL CORPORATION   (United States)

Author keywords

Dosimetry; Fetus; Gestation; Lactation; Metabolism; Neonate; PBPK model; Perinatal; Pharmacokinetic model

Indexed keywords

2 PROPANOL; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DICHLOROMETHANE; NICOTINE; TETRACHLOROETHYLENE; TOXIC SUBSTANCE; VINYL CHLORIDE;

ARTICLE; BLOOD; COMPARTMENT MODEL; DOSIMETRY; ENVIRONMENTAL EXPOSURE; HUMAN; LACTATION; LIPOPHILICITY; MATERNAL BLOOD; METABOLISM; METABOLITE; PHYSICAL CHEMISTRY; PREGNANCY; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SOLUBILITY; TOXICOKINETICS; VOLATILIZATION;

EID: 0037962096     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0273-2300(03)00047-3     Document Type: Article

References (37)

1. Andersen M., Birnbaum L., Barton H., Eklund C. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. Toxicol. Appl. Pharmacol. 144(1):1997;145-155.
2. Andersen M., Clewell H., Gargas M., Smith F., Reitz R. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87(2):1987;185-205.
3. Byczkowski J.Z., Fisher J.W. Lactational transfer of tetrachloroethylene in rats. Risk Analysis. 14(3):1994;339-349.
4. Byczkowski L.Z., Fisher J.W. A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants. Comput. Methods Programs Biomed. 46(2):1995;155-163.
5. Casey C.E., Neifert M.R., Seacat J.M., Neville M.C. Nutrient intake by breast-fed infants during the first five days after birth. Am. J. Dis. Child. 140:1986;933-936.
6. Clewell R.A., Gearhart J.M. Pharmacokinetics of toxic chemicals in breast milk: Use of PBPK models to predict infant exposure. Environmental Health Perspectives. 110(6):2002;A333-337.
7. Clewell H.J., Gearhart J.M., Gentry P.R., Covington T.R., VanLandingham C.B., Crump K.S., Shipp A.M. Evaluation of the uncertainty in an oral Reference Dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal. 19:1999;541-552.
8. Clewell H.J., Gentry P.R., Gearhart J.M., Covington T.R., Banton M.I., Andersen M.E. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol. Sci. 63:2001;160-172.
9. Clewell H.J., Gentry P.R., Gearhart J.M., Allen B.C., Andersen M.E. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Sci. Total Environ. 274(1-3):2001;37-66.
10. Clewell H., Teeguarden J., McDonald T., Sarangapani R., Lawrence G., Covington T., Gentry R., Shipp A. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol. 32(5):2002;329-389.
11. Clewell, H.J., Gentry, R., Covington, T., Sarangapani, R., Teeguarden, J., 2003. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. (submitted).
12. Fisher J., Whittaker T., Taylor D., Clewell H., Andersen M. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 102(3):1990;497-513.
13. Fisher J., Mahle D., Bankston L., Greene R., Gearhart J. Lactational transfer of volatile chemicals in breast milk. Am. Ind. Hyg. Assoc. J. 58:1997;425-431.
14. Food and Nutrition Board. 1987. Nutrition Recommendations for the Breastfeeding Woman and her Infant. Committee on Nutritional Status During Pregnancy and Lactation. Nutrition Status During Lactation Report, National Academy Press, 1991. www.mcg.edu/PedsOnL/ForHealthProf/PedNutrition/brstfeed.html.
15. Gearhart J.M., Mahle D.A., Greene R.J., Seckel C.S., Flemming C.D., Fisher J.W., Clewell H.J. Variability of physiologically-based pharmacokinetic (PB-PK) model parameters and their effects on PB-PK model predictions in a risk assessment for perchloroethylene. Toxicol. Lett. 68:1993;131-144.
16. Gentry P.R., Covington T.R., Andersen M.E., Clewell H.J. Application of a physiologically-based pharmacokinetic model for isopropanol in the derivation of an RfD/RfC. Regulat. Toxicol. Pharmacol. 36:2002;51-68.
17. Gray D.G. A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus. Toxicol. Appl. Pharmacol. 132(1):1995;91-102.
18. Hattis, D., Russ, A., Banati, P., Kozlak, M., Goble, R., Ginsberg, G. 2000. Development of a Comparative Child/Adult Pharmacokinetic Database based upon the Therapeutic Drug Literature. Draft report. Developed for NCEA/ORD, Washington, DC.
19. International Commission on Radiological Protection (ICRP). 1975. Report of the Task Group on Reference Man. Pergamon Press, Oxford. ICRP Publication 23.
20. Lee S.K., Ou Y.C., Yang R.S. Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modeling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups. Toxicol. Sci. 65(1):2002;26-34.
21. Luecke R.H., Wosilait W.D., Pearce B.A., Young J.F. A physiologically based pharmacokinetic computer model for human pregnancy. Teratology. 49(2):1994;90-103.
22. Mendrala A.L., Langvardt P.W., Nitschke K.D., Quast J.F., Nolan R.J. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch. Toxicol. 67:1993;18-27.
23. Murphy J., Janszen D., Gargas M. An in vitro method for determination of tissue partition coefficients of non-volatile chemicals such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and estradiol. J. Appl. Toxicol. 15(2):1995;147-152.
24. Pacifici G.M., Boobis A.R., Brodie M.J., McManus M.E., Davies D.S. Tissue and species differences in enzymes of epoxide metabolism. Xenobiotica. 11:1981;73-79.
25. Pelekis M., Gephart L., Lerman S. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regulat. Toxicol. Pharmacol. 33:2001;12-20.
26. Pikkarainen P.H., Räihä N.C.R. Development of alcohol dehydrogenase activity in the human liver. Pediatric Res. 1:1967;165-168.
27. Renwick A., Dorne J., Walton K. An analysis of the need for an additional uncertainty factor for infants and children. Regulat. Toxicol. Pharmacol. 31:2000;286-296.
28. Robinson D.E., Balter N.J., Schwartz S.L. A physiologically based pharmacokinetic model for nicotine and cotinine in man. J. Pharmacokinet. Biopharmaceut. 20:1992;591-609.
29. Sarangapani, R., Gentry, P.R., Covington, T.R., Clewell, H.J., 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol., in press.
30. Shelley M., Andersen M., Fisher J. A risk assessment approach for nursing infants exposed to volatile organics through the mother's occupational inhalation exposure. Appl. Ind. Hyg. 4(1):1989;21-26.
31. Sonnier M., Cresteil T. Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem. 251:1998;893-898.
32. Treluyer J.M., Gueret G., Cheron G., Sonnier M., Cresteil T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vio/in vitro correlation and inducibility. Pharmacogenetics. 7:1997;441-452.
33. US Environmental Protection Agency (USEPA). 1997. Exposure Factors Handbook. Volume I: General Factors. Office of Research and Development, Washington, DC, EPA/600/P-95/002Fa.
34. Vieira I., Sonnier M., Cresteil T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 238:1996;476-483.
35. Ward K.W., Blumenthal G.M., Welsch F., Pollack G.M. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice. Toxicol. Appl. Pharmacol. 145(2):1997;311-322.
36. Young J.F. Physiologically-based pharmacokinetic medol for pregnancy as a tool for investigation of developmental mechanisms. Comput. Biol. Med. 28(4):1998;359-364.
37. ′ -DDE in Sprague-Dawley rats Toxicol. Appl. Pharmacol. 157(2):1999;134-144.